Abstract
St. John’s wort (Hypericum perforatum) is a highly popular and effective herbal antidepressant that clinically interacts with a number of conventional drugs. Because alterations in gastric emptying can cause pharmacokinetic interactions, in the present study we evaluated the effect of a standardized extract prepared from the flowering tops of Hypericum perforatum (SJW extract) on rat gastric motility. Orally administered SJW extract delayed gastric emptying in vivo. In vitro studies showed that SJW extract was significantly more active in inhibiting acetylcholine (or prostaglandin E2)-induced contractions than electrical field stimulation (EFS)-induced contractions. The effect of SJW extract on EFS-induced contractions was unaffected by drugs that inhibit intrinsic inhibitory nerves or by tachykinin antagonists, but it was reduced by the 5-hydroxytryptamine antagonist methysergide. The inhibitory effect of SJW extract on acetylcholine-induced contractions was reduced by the sarcoplasmic reticulum Ca2+-ATPase inhibitor cyclopiazonic acid, but not by the L-type Ca2+ channel blocker nifedipine or by methysergide. Among the chemical constituents of SJW extract tested, hyperforin and, to a lesser extent, the flavonoids kaempferol and quercitrin, inhibited acetylcholine-induced contractions. It is concluded that SJW has a direct inhibitory effect on smooth muscle and could also possibly modulate gastric neurotransmission. If extended to humans, the inhibitory effect of SJW extract on gastric emptying in vivo could contribute, at least in part, to the clinical pharmacokinetic interactions between conventional medicines and this herbal antidepressant.
Similar content being viewed by others
Abbreviations
- SJW extract:
-
standardized extract prepared from the flowering tops of Hypericum perforatum
- EFS:
-
electrical field stimulation
- L-NAME:
-
NG-nitro-L-arginine methyl ester
- DMSO:
-
dimethyl sulphoxide
- hCGRP 1–29:
-
VIP antagonist [Ac-Tyr1,D-Phe2]GRF 1–29 amide
- Prostaglandin E2 :
-
PGE2
References
Abdel-Salam OM (2005) Anti-inflammatory, antinociceptive, and gastric effects of Hypericum perforatum in rats. Sci World J 5:586–595
Blumenthal M, Ferrier KLG, Cavaliere C (2006) Total sales of herbal supplements in United States show steady growth. HerbalGram 71:64–66
Borrelli F, Capasso F, Capasso R, Ascione V, Aviello G, Longo R, Izzo AA (2006) Effect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhoea without constipation. Br J Pharmacol 148:553–560
Buchholzer ML, Dvorak C, Chatterjee SS, Klein J (2002) Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John’s wort. J Pharmacol Exp Ther 301:714–719
Butterweck V, Korte B, Winterhoff H (2001) Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment. Pharmacopsychiatry 34:S2–S7
Butterweck V, Nahrstedt A, Evans J, Hufeisen S, Rauser L, Savage J, Popadak B, Ernsberger P, Roth BL (2002) In vitro receptor screening of pure constituents of St. John’s wort reveals novel interactions with a number of GPCRs. Psychopharmacology 162:193–202
Capasso R, Borrelli F, Capasso F, Mascolo N, Izzo AA (2004) Inhibitory effect of the antidepressant St. John’s wort (Hypericum perforatum) on rat bladder contractility in vitro. Urology 64:168–172
Capasso R, Borrelli F, Montanaro V, Altieri V, Capasso F, Izzo AA (2005) Effects of the antidepressant St. John’s wort (Hypericum perforatum) on rat and human vas deferens contractility. J Urol 173:2194–2197
Capasso R, Borrelli F, Capasso F, Siebert DJ, Stewart DJ, Zjawiony JK, Izzo AA (2006) The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum. Neurogastroenterol Motil 18:69–75
De Smet PA (2002) Herbal remedies. N Engl J Med 347:2046–2056
Di Carlo G, Borrelli F, Ernst E, Izzo AA (2001) St. John’s wort: Prozac from the plant kingdom. Trends Pharmacol Sci 22:292–297
El-Salhy M (2001) Gastric emptying in an animal model of human diabetes type 1: relation to endocrine cells. Acta Diabetol 38:139–144
Ernst E (1999) Second thoughts about safety of St. John’s wort. Lancet 354:2014–2016
Gambarana C, Ghiglieri O, Tolu P, De Montis MG, Giachetti D, Bombardelli E (2001) Pharmacological and endocrine effects of Hypericum perforatum and hypericin. Pharmacopsychiatry 34:S2–S7
Gershon MD, Tack J (2007) The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132:397–414
Gilani AH, Khan AU, Subhan F, Khan M (2005) Antispasmodic and bronchodilator activities of St. John’s wort are putatively mediated through dual inhibition of calcium influx and phosphodiesterase. Fund Clin Pharmacol 19:695–705
Grasa L, Rebollar E, Arruebo MP, Plaza MA, Murillo MD (2004) The role of Ca2+ in the contractility of rabbit small intestine in vitro. J Physiol Pharmacol 55:639–650
Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, Duan W, Koh HL, Zhou S (2005) Herb-drug interactions: a literature review. Drugs 65:1239–1282
Hu ZP, Yang XX, Chan SY, Xu AL, Duan W, Zhu YZ, Sheu FS, Boelsterli UA, Chan E, Zhang Q, Wang JC, Ee PL, Koh HL, Huang M, Zhou SF (2006) St. John’s wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal epithelial apoptosis. Toxicol Appl Pharmacol 216:225–237
Izzo AA (2005) Herb-drug interactions: an overview of the clinical evidence. Fund Clin Pharmacol 76:1–16
Kiewert C, Buchholzer ML, Hartmann J, Chatterjee SS, Klein J (2004) Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John’s wort. Neurosci Lett 364:195–198
Knuppel L, Linde K (2004) Adverse effects of St. John’s wort: a systematic review. J Clin Psychiatr 65:1470–1479
Koch E, Chatterjee SS (2001) Hyperforin stimulates intracellular calcium mobilisation and enhances extracellular acidification in DDT1-MF2 smooth muscle cells. Pharmacopsychiatry 34:S70–S73
Koch KL, Stern RM (1996) Functional disorders of the stomach. Semin Gastrointest Dis 7:185–195
Linde K, Berner M, Egger M, Mulrow C (2005) St. John’s wort for depression: meta-analysis of randomised controlled trials. Br J Psychiatr 186:99–107
Lipka E, Crison JR, Schug BS, Blume HH, Amidon GL (1996) Drug interaction in the gastrointestinal tract and their impact on drug absorption and systemic availability: a mechanistic review. Hand Exp Pharmacol 122:13–37
Makhlouf GM (1987) Isolated smooth muscle cells of the gut. In: Jonhson LR (ed) Physiology of the gastrointestinal tract. Raven, New York, pp. 555–570
Mannel M (2004) Drug interactions with St. John’s wort: mechanisms and clinical implications. Drug Saf 27:773–797
Mennini T, Gobbi M (2004) The antidepressant mechanism of Hypericum perforatum. Life Sci 75:1021–1027
Nocerino E, Izzo AA, Borrelli F, Capasso F, Capasso R, Pinto L, Sautebin L, Mascolo N (2002) Relaxant effect of capsazepine in the isolated rat ileum. Naunyn-Schmiedebergs Arch Pharmacol 365:187–192
Read NW, Houghton LA (1989) Physiology of gastric emptying and pathophysiology of gastroparesis. Gastroenterol Clin North Am 18:359–373
Simbrey K, Winterhoff H, Butterweck V (2004) Extracts of St. John’s wort and various constituents affect beta-adrenergic binding in rat frontal cortex. Life Sci 74:1027–1038
Szegedi A, Kohnen R, Dienel A, Kieser M (2005) Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St. John’s wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ 330:503
Tagliamonte A (1999) Efficacy of an Hypericum perforatum (St. John’s wort) extract in preventing and reverting a condition of escape deficit in rats. Neuropsychopharmacology 21:247–257
Taniyama K, Makimoto N, Furuichi A, Sakurai-Yamashita Y, Nagase Y, Kaibara M, Kanematsu T (2000) Functions of peripheral 5-ydroxytryptamine receptors, especially 5-hydroxytryptamine4 receptor, in gastrointestinal motility. J Gastroenterol 35:575–582
Tedeschi E, Menegazzi M, Margotto D, Suzuki H, Forstermann U, Kleinert H (2003) Anti-inflammatory actions of St. John’s wort: inhibition of human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha (STAT-1alpha) activation. J Pharmacol Exp Ther 307:254–261
Whitten DL, Myers SP, Hawrelak JA, Wohlmuth H (2006) The effect of St. John’s wort extracts on CYP3A: a systematic review of prospective clinical trials. Br J Clin Pharmacol 62:512–526
Williamson EM (2005) Interactions between herbal and conventional medicines. Expert Opin Drug Saf 4:355–378
Zhou S, Chan E, Pan SQ, Huang M, Lee EJ (2004) Pharmacokinetic interactions of drugs with St. John’s wort. J Psychopharmacol 18:262–276
Acknowledgements
This work was supported by PRIN, Regione Campania, and “Fondazione Enrico ed Enrica Sovena”.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Capasso, R., Borrelli, F., Aviello, G. et al. Inhibitory effect of the herbal antidepressant St. John’s wort (Hypericum perforatum) on rat gastric motility. Naunyn-Schmied Arch Pharmacol 376, 407–414 (2008). https://doi.org/10.1007/s00210-007-0230-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-007-0230-2